Published in Healthcare Finance, Tax and Law Weekly, November 2nd, 2005
"Lyophilization is essentially the process of freeze-drying reagents in micro quantities," commented Clint Severson, chairman, president and CEO of Abaxis. "Our Orbos technology enables the effective manufacturing and lyophilization of reagents and is considered one of the most effective formats for reagent utilization in molecular diagnostics."
"This agreement with Cepheid brings to three the number of major companies that are utilizing our Orbos lyophilization technology. This includes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.